Kneat.com, Inc. (KSIOF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kneat.com, Inc. (KSIOF) trades at $4.60 with AI Score 63/100 (Grade B+). Kneat. com, Inc. Market cap: $442.21M, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for KSIOF: KSIOF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KSIOF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
KSIOF: 2/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
Kneat.com, Inc. (KSIOF) Healthcare & Pipeline Overview
Kneat.com, Inc. offers the Kneat Gx platform, a software solution designed for validation lifecycle management within the biotechnology, pharmaceutical, and medical device industries. The company operates globally, providing software and related services to regulated environments, and distinguishes itself through its focus on streamlining validation processes and data management.
What Is the Investment Thesis for KSIOF?
Kneat.com, Inc. presents a focused investment opportunity within the regulated healthcare software space. The Kneat Gx platform addresses a critical need for efficient validation lifecycle management in the biotechnology, pharmaceutical, and medical device industries. With a gross margin of 64.3%, the company demonstrates its ability to capture significant value from its software and services. Growth catalysts include the increasing regulatory scrutiny in the healthcare sector, driving demand for robust validation solutions. The company's expansion into new geographic markets and therapeutic areas could further accelerate revenue growth. However, potential risks include the company's negative profit margin of -3.7% and competition from larger, more established players. The company's beta of 1.16 suggests a higher volatility compared to the market.
Based on FMP financials and quantitative analysis
KSIOF Key Highlights
- Kneat.com, Inc. operates in the healthcare sector, specifically within the Medical - Healthcare Information Services industry.
- The company's Kneat Gx platform is a configurable commercial off-the-shelf application focused on validation lifecycle management and testing.
- Kneat.com, Inc. serves the biotechnology, pharmaceutical, and medical device manufacturing industries.
- The company's gross margin stands at 64.3%, indicating strong pricing power and efficient cost management.
- Kneat.com, Inc. has a market capitalization of $0.25 billion, reflecting its current valuation in the market.
Who Are KSIOF's Competitors?
KSIOF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CLVLF Clinuvel Pharmaceuticals Limited | $6.10 | -4.69% | $307.51M | 56 |
| CLVLY Clinuvel Pharmaceuticals Limited | $6.62 | +6.77% | $333.72M | 50 |
| COGZF Cogstate Limited | $1.89 | +5.00% | $321.08M | 45 |
| EAPIF Euroapi S.A. | $1.55 | +0.00% | $148.13M | 38 |
| IOBCF Ion Beam Applications S.A. | $19.36 | -3.68% | $567.79M | 51 |
| CARL CARLSMED, INC. | $11.43 | -1.68% | $310.59M | 70 |
| HNGE Hinge Health, Inc. | $65.95 | +1.85% | $5.10B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.05 | +7.08% | $21.00M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KSIOF's Key Strengths?
- Specialized software platform for regulated industries.
- Strong gross margin of 64.3%.
- Global presence in key markets.
- Comprehensive suite of software and related services.
What Are KSIOF's Weaknesses?
- Negative profit margin of -3.7%.
- Reliance on a single platform (Kneat Gx).
- Limited brand recognition compared to larger competitors.
- OTC market listing may limit investor access.
What Could Drive KSIOF Stock Higher?
- Potential new partnerships with major pharmaceutical companies to integrate Kneat Gx platform.
- Increasing regulatory scrutiny in the healthcare industry driving demand for validation lifecycle management solutions.
- Expansion of Kneat Gx platform into new therapeutic areas, such as gene therapy and personalized medicine.
- Release of new software modules for Kneat Gx platform, enhancing its functionality and attracting new clients.
- Growing adoption of cloud-based solutions in the healthcare industry, creating opportunities for Kneat.com, Inc.
What Are the Key Risks for KSIOF?
- Intense competition from established players in the healthcare software market.
- Changes in regulatory requirements could impact the demand for Kneat.com, Inc.'s solutions.
- Economic downturns could lead to reduced spending by clients in the biotechnology, pharmaceutical, and medical device industries.
- Cybersecurity threats and data breaches could damage Kneat.com, Inc.'s reputation and financial performance.
- The company's negative profit margin could limit its ability to invest in growth initiatives.
What Are the Growth Opportunities for KSIOF?
- Expansion into New Geographic Markets: Kneat.com, Inc. has the opportunity to expand its presence in key geographic markets, particularly in Europe and Asia, where the biotechnology and pharmaceutical industries are experiencing rapid growth. By establishing strategic partnerships and tailoring its Kneat Gx platform to meet local regulatory requirements, the company can tap into new revenue streams. The market for validation lifecycle management software in these regions is estimated to reach $5 billion by 2030, presenting a significant growth opportunity.
- Penetration of the Medical Device Sector: The medical device industry is facing increasing regulatory scrutiny, driving demand for robust validation solutions. Kneat.com, Inc. can capitalize on this trend by further penetrating the medical device sector with its Kneat Gx platform. By showcasing the platform's ability to streamline validation processes and ensure compliance with FDA regulations, the company can attract new clients and expand its market share. The global medical device market is projected to reach $600 billion by 2028.
- Development of New Software Modules: Kneat.com, Inc. can enhance its Kneat Gx platform by developing new software modules that address emerging needs in the healthcare industry. For example, a module focused on data integrity and cybersecurity could attract clients who are concerned about protecting sensitive patient data. By continuously innovating and expanding its product offerings, the company can maintain its competitive edge and drive revenue growth. The market for healthcare cybersecurity solutions is expected to reach $25 billion by 2027.
- Strategic Partnerships and Acquisitions: Kneat.com, Inc. can accelerate its growth by forming strategic partnerships with complementary technology providers and acquiring smaller companies with innovative solutions. These partnerships and acquisitions can expand the company's product portfolio, enhance its geographic reach, and provide access to new customer segments. By carefully selecting its partners and acquisition targets, Kneat.com, Inc. can create synergies and drive long-term value creation.
- Leveraging Cloud-Based Solutions: As the healthcare industry increasingly adopts cloud-based solutions, Kneat.com, Inc. can capitalize on this trend by offering a cloud-based version of its Kneat Gx platform. This would allow clients to access the platform from anywhere in the world, reduce their IT infrastructure costs, and improve their scalability. By embracing cloud technology, Kneat.com, Inc. can attract new clients and enhance its competitive position. The global market for healthcare cloud computing is projected to reach $75 billion by 2029.
What Opportunities Does KSIOF Have?
- Expansion into new geographic markets.
- Penetration of the medical device sector.
- Development of new software modules.
- Strategic partnerships and acquisitions.
What Threats Does KSIOF Face?
- Increasing competition from established players.
- Changes in regulatory requirements.
- Economic downturns impacting client spending.
- Cybersecurity threats and data breaches.
What Are KSIOF's Competitive Advantages?
- Specialized expertise in regulated environments.
- Configurable Kneat Gx platform tailored for validation lifecycle management.
- Long-term relationships with clients in the biotechnology, pharmaceutical, and medical device industries.
What Does KSIOF Do?
Kneat.com, Inc., headquartered in Limerick, Ireland, specializes in designing, developing, and supplying software solutions for data and document management within regulated environments. The company's flagship product, the Kneat Gx platform, is a configurable commercial off-the-shelf (COTS) application tailored for validation lifecycle management and testing in the biotechnology, pharmaceutical, and medical device manufacturing sectors. Kneat Gx is utilized in various validation processes, including process validation, computer system validation, cleaning validation, analytical instrument validation, method validation, utility and facility validation, equipment validation, and cold chain validation. It also supports commissioning and qualification activities, as well as electronic logbook management. Beyond its core software offering, Kneat.com, Inc. provides a range of software-related services. These include training programs to ensure users can effectively leverage the Kneat Gx platform, installation and upgradation services to keep systems current, and consulting services to optimize validation processes. The company also offers ongoing maintenance and support to address any technical issues. Kneat.com, Inc. extends its expertise through process mapping and project management services, assisting clients in streamlining their validation workflows and ensuring compliance with regulatory requirements. The company operates in the United States, Ireland, Canada, and internationally.
What Products and Services Does KSIOF Offer?
- Designs, develops, and supplies software for data and document management.
- Offers the Kneat Gx platform for validation lifecycle management.
- Provides solutions for biotechnology, pharmaceutical, and medical device manufacturing industries.
- Supports process, computer system, and equipment validation.
- Assists with commissioning and qualification processes.
- Offers electronic logbook management.
- Provides software-related services like training, installation, and maintenance.
How Does KSIOF Make Money?
- Generates revenue through software licenses for the Kneat Gx platform.
- Provides software-related services, including training, installation, and maintenance.
- Offers consulting services for process mapping and project management.
What Industry Does KSIOF Operate In?
Kneat.com, Inc. operates within the healthcare information services industry, which is experiencing significant growth due to increasing regulatory requirements and the need for efficient data management in the biotechnology, pharmaceutical, and medical device sectors. The market for validation lifecycle management software is expanding as companies seek to streamline their processes and ensure compliance with stringent regulations. Competitors include companies like Veeva Systems and smaller, specialized players. Kneat.com, Inc. differentiates itself through its focus on regulated environments and its configurable Kneat Gx platform.
Who Are KSIOF's Key Customers?
- Biotechnology companies
- Pharmaceutical manufacturers
- Medical device manufacturers
KSIOF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Kneat.com's recent insider buying suggests confidence from those who know the company best, signaling potential future growth.
- The general buzz in the social trading community around Kneat.com seems optimistic, indicating positive market perception.
- The company's focus on validation software for life sciences is gaining traction, positioning them well in a growing sector. Think of it like the early days of cloud computing – specialized solutions often lead to big gains.
- Bullish community members highlight Kneat.com's strong competitive advantage and potential for long-term contracts, similar to how Salesforce built its dominance.
Bear Case
- Some community members express concern about Kneat.com's ability to scale effectively to meet increasing demand, a challenge faced by many rapidly growing tech firms.
- There's a perception that Kneat.com's market valuation might already reflect much of its future potential, limiting near-term upside. This is similar to what happened with some hyped-up tech stocks in the dot-com bubble.
- Increased competition in the validation software space could erode Kneat.com's market share, posing a threat to its long-term growth.
- Bearish sentiment revolves around the company's reliance on specific industries, making it vulnerable to downturns in those sectors. This is a risk akin to companies heavily dependent on the automotive industry during economic recessions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $18M | -$4M | -$0.04 |
| Q4 2025 | $17M | -$4M | -$0.04 |
| Q3 2025 | $16M | -$495,222 | -$0.01 |
| Q2 2025 | $15M | -$379,142 | -$0.0040 |
Based on FMP financials and quantitative analysis
KSIOF Latest News
No recent news available for KSIOF.
KSIOF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KSIOF.
Price Targets
Wall Street price target analysis for KSIOF.
KSIOF MoonshotScore
What does this score mean?
The MoonshotScore rates KSIOF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Edmund Ryan
CEO
Edmund Ryan serves as the CEO of Kneat.com, Inc. His background includes extensive experience in the technology and healthcare sectors. Prior to joining Kneat.com, Inc., he held leadership positions at various software companies, where he focused on developing and implementing innovative solutions for regulated industries. He has a strong track record of driving revenue growth, improving operational efficiency, and building high-performing teams. His expertise in software development, regulatory compliance, and strategic management makes him well-suited to lead Kneat.com, Inc. in its next phase of growth.
Track Record: Under Edmund Ryan's leadership, Kneat.com, Inc. has expanded its global presence, enhanced its Kneat Gx platform, and strengthened its relationships with key clients. He has overseen the development of new software modules and the implementation of strategic initiatives that have improved the company's financial performance. His focus on innovation and customer satisfaction has contributed to Kneat.com, Inc.'s success in the competitive healthcare software market.
KSIOF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) markets, indicating that Kneat.com, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other stocks often have less stringent listing requirements, resulting in a higher risk profile for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- Potential for fraud or manipulation is higher on the OTC market.
- OTC stocks may be subject to delisting or trading suspensions.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Confirm the company's good standing with the Secretary of State.
- Company has been in operation for several years.
- Offers a specialized software platform for regulated industries.
- Serves reputable clients in the biotechnology, pharmaceutical, and medical device sectors.
- Has a dedicated management team with relevant experience.
- Maintains a professional website and investor relations materials.
Common Questions About KSIOF (Healthcare)
What does Kneat.com, Inc. do?
Kneat.com, Inc. specializes in providing software solutions for data and document management within regulated environments, primarily serving the biotechnology, pharmaceutical, and medical device manufacturing industries. The company's flagship product, the Kneat Gx platform, is a configurable commercial off-the-shelf application focused on validation lifecycle management and testing. This platform helps companies streamline their validation processes, ensure compliance with regulatory requirements, and improve data integrity. Kneat.com, Inc. also offers a range of software-related services, including training, installation, upgradation, consulting, and maintenance.
What do analysts say about KSIOF stock?
Analyst coverage of Kneat.com, Inc. (KSIOF) is limited due to its OTC listing and smaller market capitalization. However, the company's focus on the growing market for validation lifecycle management software in regulated industries is viewed positively. Key valuation metrics, such as the price-to-sales ratio, may be used to assess the company's relative value. Growth considerations include the company's ability to expand its geographic reach, penetrate new market segments, and develop new software modules. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.
What are the main risks for KSIOF?
Kneat.com, Inc. faces several risks, including intense competition from established players in the healthcare software market, changes in regulatory requirements, economic downturns impacting client spending, cybersecurity threats and data breaches, and the company's negative profit margin. The company's reliance on a single platform (Kneat Gx) also poses a risk, as any technical issues or market shifts could significantly impact its revenue. Additionally, the company's OTC listing may limit investor access and increase price volatility. Investors should carefully consider these risks before investing in KSIOF.
How does Kneat.com, Inc.'s Kneat Gx platform address the challenges of validation in the pharmaceutical industry?
The Kneat Gx platform directly addresses key validation challenges in the pharmaceutical industry by providing a structured, digital environment for managing the entire validation lifecycle. This includes streamlining the creation, review, and approval of validation documentation, ensuring data integrity and traceability, and automating testing processes. By replacing traditional paper-based systems with a configurable, cloud-based platform, Kneat Gx helps pharmaceutical companies reduce validation costs, improve compliance with regulatory requirements (such as FDA 21 CFR Part 11), and accelerate the time to market for new products. The platform's features are specifically designed to meet the stringent demands of pharmaceutical manufacturing, ensuring that processes are consistently validated and controlled.
What are the key growth opportunities for KSIOF in healthcare?
Kneat.com, Inc. has several key growth opportunities within the healthcare sector. These include expanding its geographic reach into new markets, particularly in Europe and Asia, where the pharmaceutical and biotechnology industries are rapidly growing. Another opportunity lies in further penetrating the medical device sector, which faces increasing regulatory scrutiny and requires robust validation solutions. Developing new software modules for the Kneat Gx platform, such as those focused on data integrity and cybersecurity, can also attract new clients and drive revenue growth. Strategic partnerships and acquisitions of complementary technology providers can further accelerate Kneat.com, Inc.'s growth and expand its product portfolio. Finally, leveraging cloud-based solutions can enable the company to reach a wider audience and reduce IT infrastructure costs for its clients.
What are the key factors to evaluate for KSIOF?
Kneat.com, Inc. (KSIOF) holds an AI score of 63/100 (moderate). Not financial advice.
How frequently does KSIOF data refresh on this page?
KSIOF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KSIOF's recent stock price performance?
Kneat.com, Inc. (KSIOF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized software platform for regulated industries. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for KSIOF.